There are new features available.
View now.

Search

Type a keyword to start your search

Search for ''

news

Go to news search

Deals

Go to Deals search

Issuers

Go to Issuers search

Destinations

Go to Destinations search

IFR Extra
IFR Extra
IFR Featured
IFR Featured
SIGN IN
REQUEST A TRIAL
My IFR
My Account
My Account
Log Out

Home
People & Markets
People & Markets
Bonds
Bonds
- Global
  Bonds
  / Global
- Americas
  Bonds
  / Americas
  - Corporate
    Bonds
    / Americas
    / Corporate
    Investment Grade
    High Yield
  - SSA
  - FIG
  - LATAM
- Emea
  Bonds
  / Emea
- Asia
  Bonds
  / Asia
- Emerging Markets
  Bonds
  / Emerging Markets
Securitisation
Securitisation
ESG
ESG
Equities
Equities
Loans
Loans
Rates
Rates
Economics
Economics
FX
FX
Data
Data
New Issues
New Issues

Home
People & Markets
People & Markets
Bonds
Bonds
- Global
  Bonds
  / Global
- Americas
  Bonds
  / Americas
  - Corporate
    Bonds
    / Americas
    / Corporate
    Investment Grade
    High Yield
  - SSA
  - FIG
  - LATAM
- Emea
  Bonds
  / Emea
- Asia
  Bonds
  / Asia
- Emerging Markets
  Bonds
  / Emerging Markets
Securitisation
Securitisation
ESG
ESG
Equities
Equities
Loans
Loans
Rates
Rates
Economics
Economics
FX
FX
Data
Data
New Issues
New Issues

IFR Extra
IFR Extra
IFR Featured
IFR Featured
SIGN IN
REQUEST A TRIAL
My IFR
My Account
My Account
Log Out

There are new features available.
View now.

Search

Type a keyword to start your search

Search for ''

news

Go to news search

Deals

Go to Deals search

Issuers

Go to Issuers search

Destinations

Go to Destinations search

Create an alert Bookmark this page

Scholar Rock seeks US$275m for atrophy drug launch

2 min read

Americas

Robert Sherwood

You need to be a subscriber to view this content.

Sign in Request a trial

Top Stories from the Magazine

Commerz cuts through UniCredit uncertainties with AT1 triumph

EMEA

IFR 2554 - 05 Oct - 11 Oct

Real estate rally opens the floodgates to fresh supply

EMEA, Emerging Markets

IFR 2554 - 05 Oct - 11 Oct

Water torture: crunch time arrives for Thames

BON SEC P&M ESG

EMEA

IFR 2554 - 05 Oct - 11 Oct

Christopher Spink, Alex Chambers, Sudip Roy

Ergen shows cards in Dish debt game

Americas

IFR 2554 - 05 Oct - 11 Oct

Portfolio trading surges – and heads multi-asset

Americas

IFR 2554 - 05 Oct - 11 Oct

Christopher Whittall

Cerebras hopes to capture AI buzz with US$1bn Nasdaq debut

Americas

IFR 2554 - 05 Oct - 11 Oct

Kbank leads Korean IPO wave

Asia

IFR 2554 - 05 Oct - 11 Oct

Pfizer collects £2.66bn from Haleon sale

EMEA

IFR 2554 - 05 Oct - 11 Oct

Big long-only bid for Springer Nature IPO

EMEA

IFR 2554 - 05 Oct - 11 Oct

New York climate week goes nuclear

Americas

IFR 2554 - 05 Oct - 11 Oct

US ABS supply poised for record in 2024

Americas

IFR 2554 - 05 Oct - 11 Oct

Middle East issuers undeterred by regional conflicts

EMEA, Emerging Markets

IFR 2554 - 05 Oct - 11 Oct

Adani bonds draw strong demand

Emerging Markets, Asia

IFR 2554 - 05 Oct - 11 Oct

Krishna Merchant

Alaska Air takes secured route

Americas, EMEA

IFR 2554 - 05 Oct - 11 Oct

About Us Contact Us Advertise Events IFR Help Special Reports Roundtables IFR Awards IFR Asia Awards

My IFR Alerts Bookmarks Saved Searches Account Settings

Privacy & Cookies

Copyright & Disclaimer

Browser Requirements

© 2024 London Stock Exchange Group. All rights reserved.

Copyright & Disclaimer

© 2024 London Stock Exchange Group. All rights reserved.

Our Privacy Statement & Cookie Policy

All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

Privacy Statement Cookie Policy